Sanarus Technologies | 1,090 followers on LinkedIn. Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system.

Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors. It offers Visica treatment system for cryoablation of breast fibroadenomas; Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and ImarC tissue marker system, a

Sanarus is dedicated to helping people worldwide achieve their health goals through effective, precise, and science-backed solutions, striving to be the global leader in skin tag

Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors.

Sanarus Investment Management is an integrated asset management business providing a full spectrum of investment solutions, including hedge funds, private equity investments, Exchange Traded Funds (ETFs).

2021年11月19日 · 2014年，赛昂医疗科技全资收购美国Sanarus公司乳腺冷冻活检系统及其相关专利技术。 随后在2015年，公司又全资收购美国Beacon公司的乳腺标记物及其 ...

Sanarus is in the business of Women’s Health committed to enhance the Standard of Care for breast tumors. Made in the USA, we are the inventor of breast cryotechnology devices offering physicians a procedure that improves their economics, is performed in an office setting and has a 97% patient satisfaction rate.

1999年1月1日 · Sanarus Medical, Inc. 开发和销售用于乳腺肿瘤诊断和治疗的微创设备。 它为乳腺纤维腺瘤的冷冻消融提供 Visica 治疗系统和Cassi II 旋转核心活检系统，一种用于固定连续活检样本的自动化手持式乳腺活检设备；和 ImarC 组织标记系统，在成像模式下可见的一系列乳房 ...

了解Sanarus Medical, Inc. (Sanarus Medical, Inc.)公司的药物管线，治疗领域，技术平台，以及它的。

At Sanarus, we apply cryotherapy to treat breast diseases such as fibroadenomas (benign breast tumors) and breast cancer in a clinical trial setting (learn more about our FROST clinical study for breast cancer here).